Wells Fargo & Company Insmed Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Insmed Inc stock. As of the latest transaction made, Wells Fargo & Company holds 127,495 shares of INSM stock, worth $9.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127,495

Previous 209,130 39.04%

Holding current value

$9.42 Million

Previous $14 Million 33.57%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$62.0 - $79.01 $5.06 Million - $6.45 Million	-81,635 Reduced 39.04%	127,495 $9.31 Million
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $3.03 Million - $9.6 Million	137,677 Added 192.68%	209,130 $14 Million
Q1 2024 May 10, 2024	SELL	$25.72 - $29.94 $640,273 - $745,326	-24,894 Reduced 25.84%	71,453 $1.94 Million
Q4 2023 Feb 09, 2024	SELL	$23.42 - $31.74 $403,971 - $547,483	-17,249 Reduced 15.18%	96,347 $2.99 Million
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $598,103 - $811,023	-30,116 Reduced 20.96%	113,596 $2.87 Million
Q2 2023 Aug 15, 2023	BUY	$16.44 - $21.1 $444,800 - $570,881	27,056 Added 23.19%	143,712 $3.03 Million
Q1 2023 May 12, 2023	BUY	$16.26 - $21.73 $1.55 Million - $2.08 Million	95,574 Added 453.34%	116,656 $1.99 Million
Q4 2022 Feb 13, 2023	SELL	$16.98 - $23.15 $81,962 - $111,745	-4,827 Reduced 18.63%	21,082 $421,000
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $11,776 - $15,910	-564 Reduced 2.13%	25,909 $558,000
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $912,135 - $1.37 Million	-53,435 Reduced 66.87%	26,473 $521,000
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $800,954 - $1.1 Million	-39,224 Reduced 32.92%	79,908 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $903,638 - $1.17 Million	-34,903 Reduced 22.66%	119,132 $3.25 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $1.77 Million - $2.32 Million	-78,729 Reduced 33.82%	154,035 $4.24 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $164,186 - $244,615	6,793 Added 3.01%	232,764 $6.63 Million
Q1 2021 May 13, 2021	SELL	$32.28 - $44.3 $839,699 - $1.15 Million	-26,013 Reduced 10.32%	225,971 $7.7 Million
Q4 2020 Feb 09, 2021	BUY	$31.45 - $40.54 $3.28 Million - $4.23 Million	104,232 Added 70.55%	251,984 $8.39 Million
Q3 2020 Nov 05, 2020	BUY	$26.0 - $34.5 $940,004 - $1.25 Million	36,154 Added 32.4%	147,752 $4.75 Million
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $540,384 - $1.13 Million	38,298 Added 52.25%	111,598 $3.07 Million
Q1 2020 May 14, 2020	BUY	$13.63 - $33.98 $999,079 - $2.49 Million	73,300 New	73,300 $1.18 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Insmed Inc Transaction History